The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 05, 2005
Filed:
Aug. 30, 2002
Jesper Lau, Farum, DK;
Peter Madsen, Bagsværd, DK;
Christian Sams, Frederiksberg, DK;
Carsten Behrens, Copenhagen, DK;
Inge Thøger Christensen, Lyngby, DK;
Behrend Frederik Lundt, Kokkedal, DK;
Ulla Grove Sidelmann, Vedbæk, DK;
Henning Thøgersen, Farum, DK;
Anthony L. Ling, San Diego, CA (US);
Michael Bruno Plewe, San Diego, CA (US);
Larry Kenneth Truesdale, San Diego, CA (US);
Anker Steen Jøgensen, Copenhagen, DK;
Janos Tibor Kodra, Copenhagen, DK;
Shenghua Shi, San Diego, CA (US);
Jesper Lau, Farum, DK;
Peter Madsen, Bagsværd, DK;
Christian Sams, Frederiksberg, DK;
Carsten Behrens, Copenhagen, DK;
Inge Thøger Christensen, Lyngby, DK;
Behrend Frederik Lundt, Kokkedal, DK;
Ulla Grove Sidelmann, Vedbæk, DK;
Henning Thøgersen, Farum, DK;
Anthony L. Ling, San Diego, CA (US);
Michael Bruno Plewe, San Diego, CA (US);
Larry Kenneth Truesdale, San Diego, CA (US);
Anker Steen Jøgensen, Copenhagen, DK;
Janos Tibor Kodra, Copenhagen, DK;
Shenghua Shi, San Diego, CA (US);
Novo Nordisk A/S, Bagsvaerd, DK;
Abstract
A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any glucagon-mediated conditions and diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and obesity.